comparemela.com

Latest Breaking News On - Analyst recommendations for olema pharmaceuticals - Page 3 : comparemela.com

Brokerages Set Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Price Target at $21.20

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) has earned a consensus rating of “Buy” from the six ratings firms that are currently covering the firm, MarketBeat.com reports. Six investment analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have updated their coverage on the stock in […]

Canada
Cyrus-harmon
Citigroup-inc
Jpmorgan-chase-co
Olema-pharmaceuticals
Virtu-financial
Nasdaq
Olema-pharmaceuticals-company-profile
Olema-pharmaceuticals-trading
Royal-bank
Securities-exchange-commission
Hedge-funds-weigh-in-on-olema-pharmaceuticals

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Average Rating of "Buy" by Brokerages

Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) have received an average recommendation of “Buy” from the six ratings firms that are currently covering the company, Marketbeat.com reports. Six research analysts have rated the stock with a buy rating. The average 1 year target price among brokers that have covered the stock in […]

Cyrus-harmon
Davidc-myles
Credit-suisse-group
Geode-capital-management
Nasdaq
Institutional-trading-of-olema-pharmaceuticals
Dimensional-fund-advisors
Olema-pharmaceuticals
Olema-pharmaceuticals-stock
Analyst-recommendations-for-olema-pharmaceuticals
Millennium-management
Olema-pharmaceuticals-inc

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives $19.40 Consensus Target Price from Brokerages

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) has earned a consensus recommendation of “Buy” from the six research firms that are covering the company, MarketBeat reports. Six analysts have rated the stock with a buy recommendation. The average 1-year target price among brokerages that have issued ratings on the stock in the last year […]

California
United-states
Cyrus-harmon
Wells-fargo-company
Jpmorgan-chase-co
Institutional-investors-weigh-in-on-olema-pharmaceuticals
Nuveen-asset-management
Olema-pharmaceuticals-stock
Securities-exchange-commission
News-ratings-for-olema-pharmaceuticals-daily
Olema-pharmaceuticals-inc
Analyst-recommendations-for-olema-pharmaceuticals

Olema Pharmaceuticals (NASDAQ:OLMA) Rating Reiterated by Oppenheimer

Oppenheimer reaffirmed their outperform rating on shares of Olema Pharmaceuticals (NASDAQ:OLMA – Free Report) in a research note released on Wednesday morning, Benzinga reports. The brokerage currently has a $21.00 target price on the stock. Other research analysts have also recently issued research reports about the company. Capital One Financial increased their target price on […]

Canada
California
United-states
Cyrus-harmon
Royal-bank
News-ratings-for-olema-pharmaceuticals-daily
Olema-pharmaceuticals-company-profile
Analyst-recommendations-for-olema-pharmaceuticals
Wells-fargo-company
Olema-pharmaceuticals-stock-performance
Olema-pharmaceuticals
Credit-suisse-group

Oppenheimer Reaffirms Outperform Rating for Olema Pharmaceuticals (NASDAQ:OLMA)

Oppenheimer Reaffirms Outperform Rating for Olema Pharmaceuticals (NASDAQ:OLMA)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada
Cyrus-harmon
Virtu-financial
News-ratings-for-olema-pharmaceuticals-daily
Jpmorgan-chase-co
Olema-pharmaceuticals-trading-down
Olema-pharmaceuticals-inc
Credit-suisse-group
Olema-pharmaceuticals-company-profile
Analyst-recommendations-for-olema-pharmaceuticals
Olema-pharmaceuticals
Royal-bank

vimarsana © 2020. All Rights Reserved.